Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of ZPL389 in Adult Atopic Dermatitis
NCT03948334Phase 2Terminated
- Sponsor
- Novartis
- Start
- Apr 2019
- Primary completion
- Jul 2020
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 13
01
Overview
A Phase 2 trial of ZPL389 + topical corticosteroids + topical calcineurin inhibitors in atopic dermatitis (AD), sponsored by Novartis. Started Apr 2019; status: terminated.
02
Drugs
ZPL389 + topical corticosteroids + topical calcineurin inhibitors
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03948334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948334.